Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01866878
Other study ID # 12-PP-13
Secondary ID
Status Completed
Phase N/A
First received April 30, 2013
Last updated March 8, 2018
Start date July 30, 2013
Est. completion date July 28, 2015

Study information

Verified date March 2018
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sensory disorders in patients with multiple sclerosis are among the most common symptoms encountered.

A functional impairment based on sensory disorders of the hand. The hand is a sensory organ that transmits the cerebral cortex protopathic sensitive information, proprioceptive or epicritiques. The view-hand association plays an important role in the understanding of the environment. Its exploratory use remains an essential and voluntary basis. The process of recognition of the object passes through manipulation, but operates instantaneously. The brain is able to do a quick summary of the information it receives to determine the nature of the manipulated object. The exploration takes a posteriori, the brain can then determine the details component object (texture, shape, composition, temperature and weight).

Neurophysiological mechanisms that would explain the analgesic effects of transcutaneous electrical nerve stimulation (TENS) are not fully understood. Several theories underlying its use as a neuromodulator of pain. The gate control theory has led to the development of TENS devices. Recruitment of myelinated, large caliber, by the TENS electrodes afferent fibers increases the control exerted on spinal level, thereby inhibiting the action of afferent fibers of small caliber related to nociception. This stimulation strengthens the blocking of "gate" at the corresponding cell bodies of spinothalamic tract and reduces the transmission of nociceptive impulses to the spinal cord dorsal horn. This is segmental presynaptic inhibition depends on the area and stimulated.

The objective of this study is to improve the quality of life through improved sensitivity disorders of the hand in patients with MS, thanks to reeducation of the hand.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date July 28, 2015
Est. primary completion date July 28, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with relapsing remitting MS defined according to Poser criteria [9] and McDonald [5].

- Age = 18 years, male or female sex

- Patients with sensory disorders interesting hands, evidenced by clinical examination objective.

- Patients with an EDSS between 2 and 4 with functional sensitivity parameter = 2.

- Patients affiliated to a social security scheme.

- Patients signed informed consent for the study.

Exclusion Criteria:

- Patients with other central or peripheral disorders may affect the sensitivity of the hand.

- Patients with allodynia in the study area

- Patients with a motor and / or deficit cerebellar ataxia of the upper limbs.

- Patients treated with psychotropic or antiepileptic drugs.

- Patients for whom a flare occurred affecting the sensitivity of the hand, within 30 days before enrollment.

- Patients holders of an active implantable medical device.

- Pregnant women and vulnerable patient population.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
equipment rehabilitation stereognosis

TENS


Locations

Country Name City State
France Hôpital Pasteur Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare quality of life between baseline and procedure Improve the quality of life through improved sensitivity disorders of the hand in patients with MS, thanks to reeducation of the hand.
Unit of mesure: scale MusiQoL
frist day, 1 month and 3 month
Secondary Compare the performance during functional tests between baseline and procedure Improve performance of MS patients during functional tests in patients undergoing rehabilitation treatment compared to the control group.
Using picking up test and thr Nine Hole Peg Test
first day, 1 month and 3 month
Secondary Compare the improvement clinically sensitive target from baseline procedure Improve clinically sensitive target of MS patients through a rehabilitation treatment compared to the control group.
Using the Threshold pressure, the Threshold to the vibration and the Weber test.
first day, 1 month and 3 month
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4